Enhancement of radiosensitivity of oral carcinoma cells by iodinated chlorin p6 copper complex in combination with synchrotron X-ray radiation

Journal of Synchrotron Radiation
Paromita Sarbadhikary, Alok Dube

Abstract

The combination of synchrotron X-ray radiation and metal-based radiosensitizer is a novel form of photon activation therapy which offers the advantage of treating malignant tumors with greater efficacy and higher precision than conventional radiation therapy. In this study the anticancer cytotoxic efficacy of a new chlorophyll derivative, iodinated chlorin p6 copper complex (ICp6-Cu), combined with synchrotron X-ray radiation (8-10 keV) in two human oral cancer cell lines is explored. Pre-treatment of cells with 20 µM and 30 µM ICp6-Cu for 3 h was found to enhance the X-ray-induced cytotoxicity with sensitization enhancement ratios of 1.8 and 2.8, respectively. ICp6-Cu localized in cytoplasm, mainly in lysosomes and endoplasmic reticulum, and did not cause any cytotoxicity alone. The radiosensitization effect of ICp6-Cu accompanied a significant increase in the level of reactive oxygen species, damage to lysosomes, inhibition of repair of radiation-induced DNA double-strand breaks, increase in cell death and no significant effect on cell cycle progression. These results demonstrate that ICp6-Cu is a potential agent for synchrotron photon activation therapy of cancer.

References

Oct 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F ZölzerC Streffer
Nov 30, 2000·Nucleic Acids Research·J J TurchiY Zhou
Sep 24, 2004·International Journal of Radiation Oncology, Biology, Physics·Akihisa TakahashiTakeo Ohnishi
Apr 9, 2005·The Biochemical Journal·H Lennart PerssonUlf T Brunk
Dec 13, 2005·International Journal of Radiation Oncology, Biology, Physics·Jean-François AdamHélène Elleaume
Apr 15, 2008·Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)·J F AdamH Elleaume
Jul 23, 2008·The Journal of Pharmacy and Pharmacology·James F HainfeldHenry M Smilowitz
Jan 16, 2010·Mutation Research·K KobayashiC Le Sech
Feb 5, 2010·Leukemia·L-J MahT C Karagiannis
Jun 12, 2010·La Revue de médecine interne·P DemanF Estève
Aug 7, 2010·Advances in Experimental Medicine and Biology·Zbigniew DarzynkiewiczHong Zhao
Oct 7, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·S GilM Sabés
Aug 21, 2013·Journal of Synchrotron Radiation·Clement RicardBoudewijn van der Sanden
Jan 13, 2015·Journal of Cancer Research and Therapeutics·Renu DayalKaushala Prasad Mishra
Apr 26, 2015·Cancer Letters·Jing ZhangLun-Quan Sun
May 20, 2015·Physics in Medicine and Biology·Florence TaupinHélène Elleaume
Feb 11, 2016·The Biochemical Journal·Heidi Abrahamse, Michael R Hamblin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.